The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Stingray Surgical Products sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Stingray Surgical Products is a medical equipment company that manufactures electrosurgical, gynecological, and cosmetic instruments. The company’s product portfolio includes bipolar forceps, accessories, and non-conductive instruments. Its products are used in OEM manufacturing, distributors, and surgery centers and hospitals. Stingray Surgical Products is headquartered in Boca Raton, Florida, the US.
The key metrics of Stingray Surgical Products related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Stingray Surgical Products is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Stingray Surgical Products.
For a detailed understanding of the performance of Stingray Surgical Products, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.